Cleared Abbreviated

K131913 - INTELLIVUE CL SPO2 POD AND CL NBP POD, PHILIPS INTELLIVUE PATIENT MONITORS MP5, MP5T, MP5SC (FDA 510(k) Clearance)

Nov 2013
Decision
153d
Days
Class 2
Risk

K131913 is an FDA 510(k) clearance for the INTELLIVUE CL SPO2 POD AND CL NBP POD, PHILIPS INTELLIVUE PATIENT MONITORS MP5, MP5T, MP5SC. This device is classified as a Transmitters And Receivers, Physiological Signal, Radiofrequency (Class II - Special Controls, product code DRG).

Submitted by Philips Medizin Systeme Boeblingen GmbH (Boeblingen, Bw, DE). The FDA issued a Cleared decision on November 26, 2013, 153 days after receiving the submission on June 26, 2013.

This device falls under the Cardiovascular FDA review panel. Regulated under 21 CFR 870.2910.

Submission Details

510(k) Number K131913 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 26, 2013
Decision Date November 26, 2013
Days to Decision 153 days
Submission Type Abbreviated
Review Panel Cardiovascular (CV)
Summary Summary PDF

Device Classification

Product Code DRG — Transmitters And Receivers, Physiological Signal, Radiofrequency
Device Class Class II - Special Controls
CFR Regulation 21 CFR 870.2910